{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T09:52:23Z","timestamp":1694771543714},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Previous clinical studies have reported that furosemide can be used to treat liver cirrhosis (LC) effectively. However, no study systematically explored this issue. This systematic review aims to investigate the efficacy and safety of furosemide for treatment of LC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This study will be conducted through searching the following literature sources from their inception to February 28, 2019 without any language limitations: PUBMED, EMBASE, PsycINFO, Web of Science, Scopus, OpenGrey, Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, Allied and Complementary Medicine Database, and Chinese Biomedical Literature Database. In addition, reference lists of relevant reviews and websites of clinical trial registry will also be searched. Only randomized controlled trials of furosemide for treatment of LC will be included in this study. Two reviewers will independently select studies, collect data, and determine risk of bias. RevMan 5.3 software will be used to pool the data and to conduct meta-analysis if sufficient studies will be included with acceptable heterogeneity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This study will investigate the efficacy and safety of furosemide for LC by the assessment of primary and secondary outcomes. The primary outcome includes mortality rate. The secondary outcomes consist of response rate, overall survival, body weight, urinary volume, quality of life, as measured by any relevant scales, and adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The results of this study may provide summarized evidence of furosemide for the treatment of LC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>No individual patient data will be used in this study, thus no ethics approval is needed. The findings of this study will be published in peer-reviewed journals.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000015300","type":"journal-article","created":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T01:38:45Z","timestamp":1555724325000},"page":"e15300","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of furosemide for treatment of liver cirrhosis"],"prefix":"10.1097","volume":"98","author":[{"given":"Zheng-Ri","family":"Zhu","sequence":"first","affiliation":[{"name":"Second Ward of Gastroenterology Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Lu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nursing Care"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Min","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Cardiac Intensive Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Affiliated Hongqi Hospital of Mudanjiang Medical University, Mudanjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/NSS.S186665","article-title":"Sleep disturbances in patients with liver cirrhosis: prevalence, impact, and management challenges","volume":"10","author":"Bruyneel","year":"2018","journal-title":"Nat Sci Sleep"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3747\/pdi.2018.00008","article-title":"Peritoneal dialysis for patients with end-stage renal disease and liver cirrhosis","volume":"38","author":"Khan","year":"2018","journal-title":"Perit Dial Int"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"e0186990","DOI":"10.1371\/journal.pone.0186990","article-title":"Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3748\/wjg.15.280","article-title":"Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management","volume":"15","author":"Garcia-Compean","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0272-5231(05)70298-7","article-title":"Mechanisms of gas exchange impairment in patients with liver cirrhosis","volume":"17","author":"Agusti","year":"1996","journal-title":"Clin Chest Med"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5009\/gnl15458","article-title":"Therapy with direct-acting antiviral agents for hepatitis C-related liver cirrhosis","volume":"11","author":"Toshikuni","year":"2017","journal-title":"Gut Liver"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"e69430","DOI":"10.1371\/journal.pone.0069430","article-title":"Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review","volume":"8","author":"Shimakawa","year":"2013","journal-title":"PLoS One"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.3748\/wjg.v20.i23.7217","article-title":"Influence of unrecorded alcohol consumption on liver cirrhosis mortality","volume":"20","author":"Lachenmeier","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00535-016-1216-y","article-title":"Evidence-based clinical practice guidelines for liver cirrhosis 2015","volume":"51","author":"Fukui","year":"2016","journal-title":"J Gastroenterol"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"189","DOI":"10.15171\/mejdd.2017.73","article-title":"Improving quality of care in patients with liver cirrhosis","volume":"9","author":"Saberifiroozi","year":"2017","journal-title":"Middle East J Dig Dis"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1210\/js.2017-00183","article-title":"Diagnosis and clinical implications of diabetes in liver cirrhosis: a focus on the oral glucose tolerance test","volume":"1","author":"Nishida","year":"2017","journal-title":"J Endocr Soc"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J Hepatol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med"},{"key":"R14-20230914","first-page":"2335","article-title":"Effect of diuretics on renal function.","author":"Puschet","year":"1992","journal-title":"Handbookof physiology"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0016-5085(83)80119-X","article-title":"Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites","volume":"84","author":"Planas","year":"1983","journal-title":"Gastroenterology"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-230X-6-39","article-title":"The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis","volume":"6","author":"Assy","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"27502","DOI":"10.25011\/cim.v39i6.27502","article-title":"High dose oral furosemide with salt ingestion in the treatment of refractory ascites of liver cirrhosis","volume":"39","author":"Yakar","year":"2016","journal-title":"Clin Invest Med"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00535-010-0240-6","article-title":"A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis","volume":"45","author":"Okita","year":"2010","journal-title":"J Gastroenterol"},{"key":"R19-20230914","first-page":"178","article-title":"Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial","volume":"44","author":"Degoricija","year":"2003","journal-title":"Croat Med J"},{"key":"R20-20230914","first-page":"212","article-title":"Analysis of the curative effect on ascites in liver cirrhosis by integrated traditional Chinese and Western medicine","volume":"22","author":"Xia","year":"1997","journal-title":"Hunan Yi Ke Da Xue Xue Bao"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0676.1993.tb00624.x","article-title":"Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content","volume":"13","author":"Bernardi","year":"1993","journal-title":"Liver"},{"key":"R22-20230914","first-page":"751","article-title":"Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin","volume":"16","author":"Hag\u00e8ge","year":"1992","journal-title":"Gastroenterol Clin Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201904190-00061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:36:41Z","timestamp":1694723801000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201904190-00061"}},"subtitle":["A systematic review protocol of randomized controlled trial"],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":22,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000015300","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}